{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:24:25Z","timestamp":1790148265979,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.bbrc.2016.11.083","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T13:47:24Z","timestamp":1479304044000},"page":"625-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Rutin suppresses human-amylin\/hIAPP misfolding and oligomer formation in-vitro , and ameliorates diabetes and its impacts in human-amylin\/hIAPP transgenic mice"],"prefix":"10.1016","volume":"482","author":[{"given":"Jacqueline F.","family":"Aitken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry M.","family":"Loomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Riba-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Unwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Prijic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley S.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally D.","family":"Poppitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perdita E.","family":"Barran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Dowsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth J.S.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2016.11.083_bib1","series-title":"The Global Burden: Diabetes and Impaired Glucose Tolerance International Diabetes Federation","author":"IDF","year":"2013"},{"key":"10.1016\/j.bbrc.2016.11.083_bib2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","article-title":"Type 2 diabetes: principles of pathogenesis and therapy","volume":"365","author":"Stumvoll","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2016.11.083_bib3","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2016.11.083_bib4","first-page":"193","article-title":"Molecular and metabolic mechanisms of insulin resistance and \u03b2-cell failure in type 2 diabetes","volume":"9","author":"Muoio","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2016.11.083_bib5","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.11.083_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1210\/edrv-15-2-163","article-title":"Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease","volume":"15","author":"Cooper","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbrc.2016.11.083_bib7","doi-asserted-by":"crossref","first-page":"13992","DOI":"10.1073\/pnas.0906471106","article-title":"Pancreatic islet amyloidosis, \u03b2-cell apoptosis, and \u03b1-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons","volume":"106","author":"Guardado-Mendoza","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.11.083_bib8","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1096\/fj.14-251744","article-title":"The pathogenic mechanism of diabetes varies with the degree of overexpression and oligomerization of human amylin in the pancreatic islet beta-cells","volume":"28","author":"Zhang","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2016.11.083_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2337\/db09-0548","article-title":"Tetracycline treatment retards the onset and slows the progression of diabetes in human amylin\/hIAPP transgenic mice","volume":"59","author":"Aitken","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2016.11.083_bib10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1042\/bj20030422","article-title":"Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid","volume":"374","author":"Aitken","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2016.11.083_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbrc.2016.11.083_bib12","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.2337\/db06-1755","article-title":"Spontaneous diabetes in hemizygous human amylin transgenic mice that developed neither islet amyloid nor peripheral insulin resistance","volume":"57","author":"Wong","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2016.11.083_bib13","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0022-2836(02)01377-3","article-title":"Full-length rat amylin forms fibrils following substitution of single residues from human amylin","volume":"326","author":"Green","year":"2003","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2016.11.083_bib14","doi-asserted-by":"crossref","first-page":"9662","DOI":"10.1073\/pnas.86.24.9662","article-title":"Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus","volume":"86","author":"Roberts","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.11.083_bib15","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1039\/C4AN02306D","article-title":"Conformational dynamics of alpha-synuclein: insights from mass spectrometry","volume":"140","author":"Phillips","year":"2015","journal-title":"Analyst"},{"key":"10.1016\/j.bbrc.2016.11.083_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijms.2015.09.001","article-title":"On the structure of the copper-amylin complex","volume":"391","author":"Riba","year":"2015","journal-title":"Int. J. Mass Spectrom."},{"key":"10.1016\/j.bbrc.2016.11.083_bib17","series-title":"Data Describing the Impact of the Flavonol Rutin, on the Blood-glucose Profiles, Fluid-intake Profiles and Survival of Human Amylin Transgenic Mice","author":"Aitken","year":"2016"},{"key":"10.1016\/j.bbrc.2016.11.083_bib18","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/jn\/138.9.1615","article-title":"Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans","volume":"138","author":"Egert","year":"2008","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.bbrc.2016.11.083_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000399407","article-title":"The flavonoids. A class of semi-essential food components: their role in human nutrition","volume":"24","author":"Kuhnau","year":"1976","journal-title":"World Rev. Nutr. Diet."},{"key":"10.1016\/j.bbrc.2016.11.083_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/10715769900301141","article-title":"The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man","volume":"31","author":"Hollman","year":"1999","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bbrc.2016.11.083_bib21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/00912700122010366","article-title":"Pharmacokinetics and bioavailability of quercetin glycosides in humans","volume":"41","author":"Graefe","year":"2001","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2016.11.083_bib22","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.2337\/diabetes.52.9.2304","article-title":"Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2016.11.083_bib23","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/diabetes.53.6.1509","article-title":"Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes","volume":"53","author":"Butler","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2016.11.083_bib24","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","article-title":"Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide","volume":"93","author":"Janson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.11.083_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2016.11.083_bib26","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1038\/35017124","article-title":"Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?","volume":"2","author":"Goldberg","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2016.11.083_bib27","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0002-9440(10)63050-7","article-title":"Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates","volume":"159","author":"Sousa","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2016.11.083_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.phrs.2004.06.002","article-title":"Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and \u03b2-cell damage in rat pancreas","volume":"51","author":"Coskun","year":"2005","journal-title":"Pharmacol. Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16319465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16319465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T16:42:09Z","timestamp":1568565729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X16319465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0006291X16319465"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.11.083","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rutin suppresses human-amylin\/hIAPP misfolding and oligomer formation in-vitro, and ameliorates diabetes and its impacts in human-amylin\/hIAPP transgenic mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.11.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}